Recent advances in high-throughput platforms with engineered biomaterial microarrays for screening of cell and tissue behavior

Kijun Park, Yeontaek Lee, Jungmok Seo

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

In the last decades, bioengineers have developed myriad biomaterials for regenerative medicine. Development of screening techniques is essential for understanding complex behavior of cells in the biological microenvironments. Conventional approaches to the screening of cellular behavior in vitro have limitations in terms of accuracy, reusability, labor-intensive screening, and versatility. Thus, drug screening and toxicology test through in vitro screening platforms have been underwhelming. Recent advances in the high-throughput screening platforms somewhat overcome the limitations of in vitro screening platforms via repopulating human tissues’ biophysical and biomchemical microenvironments with the ability to continuous monitoring of miniaturized human tissue behavior. Herein, we review current trends in the screening platform in which a high-throughput system composed of engineered microarray devices is developed to investigate cell-biomaterial interaction. Furthermore, diverse methods to achieve continuous monitoring of cell behavior via developments of biosensor integrated high-throughput platforms, and future perspectives on high-throughput screening will be provided.

Original languageEnglish
Pages (from-to)5458-5470
Number of pages13
JournalCurrent Pharmaceutical Design
Volume24
Issue number45
DOIs
Publication statusPublished - 2018 Jan 1

Fingerprint

Biocompatible Materials
Preclinical Drug Evaluations
Aptitude
Regenerative Medicine
Biosensing Techniques
Cell Communication
Toxicology
Equipment and Supplies
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cite this

@article{c93e6acb1a6d4afaa5fb1fc1260cd458,
title = "Recent advances in high-throughput platforms with engineered biomaterial microarrays for screening of cell and tissue behavior",
abstract = "In the last decades, bioengineers have developed myriad biomaterials for regenerative medicine. Development of screening techniques is essential for understanding complex behavior of cells in the biological microenvironments. Conventional approaches to the screening of cellular behavior in vitro have limitations in terms of accuracy, reusability, labor-intensive screening, and versatility. Thus, drug screening and toxicology test through in vitro screening platforms have been underwhelming. Recent advances in the high-throughput screening platforms somewhat overcome the limitations of in vitro screening platforms via repopulating human tissues’ biophysical and biomchemical microenvironments with the ability to continuous monitoring of miniaturized human tissue behavior. Herein, we review current trends in the screening platform in which a high-throughput system composed of engineered microarray devices is developed to investigate cell-biomaterial interaction. Furthermore, diverse methods to achieve continuous monitoring of cell behavior via developments of biosensor integrated high-throughput platforms, and future perspectives on high-throughput screening will be provided.",
author = "Kijun Park and Yeontaek Lee and Jungmok Seo",
year = "2018",
month = "1",
day = "1",
doi = "10.2174/1381612825666190207093438",
language = "English",
volume = "24",
pages = "5458--5470",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "45",

}

Recent advances in high-throughput platforms with engineered biomaterial microarrays for screening of cell and tissue behavior. / Park, Kijun; Lee, Yeontaek; Seo, Jungmok.

In: Current Pharmaceutical Design, Vol. 24, No. 45, 01.01.2018, p. 5458-5470.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Recent advances in high-throughput platforms with engineered biomaterial microarrays for screening of cell and tissue behavior

AU - Park, Kijun

AU - Lee, Yeontaek

AU - Seo, Jungmok

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In the last decades, bioengineers have developed myriad biomaterials for regenerative medicine. Development of screening techniques is essential for understanding complex behavior of cells in the biological microenvironments. Conventional approaches to the screening of cellular behavior in vitro have limitations in terms of accuracy, reusability, labor-intensive screening, and versatility. Thus, drug screening and toxicology test through in vitro screening platforms have been underwhelming. Recent advances in the high-throughput screening platforms somewhat overcome the limitations of in vitro screening platforms via repopulating human tissues’ biophysical and biomchemical microenvironments with the ability to continuous monitoring of miniaturized human tissue behavior. Herein, we review current trends in the screening platform in which a high-throughput system composed of engineered microarray devices is developed to investigate cell-biomaterial interaction. Furthermore, diverse methods to achieve continuous monitoring of cell behavior via developments of biosensor integrated high-throughput platforms, and future perspectives on high-throughput screening will be provided.

AB - In the last decades, bioengineers have developed myriad biomaterials for regenerative medicine. Development of screening techniques is essential for understanding complex behavior of cells in the biological microenvironments. Conventional approaches to the screening of cellular behavior in vitro have limitations in terms of accuracy, reusability, labor-intensive screening, and versatility. Thus, drug screening and toxicology test through in vitro screening platforms have been underwhelming. Recent advances in the high-throughput screening platforms somewhat overcome the limitations of in vitro screening platforms via repopulating human tissues’ biophysical and biomchemical microenvironments with the ability to continuous monitoring of miniaturized human tissue behavior. Herein, we review current trends in the screening platform in which a high-throughput system composed of engineered microarray devices is developed to investigate cell-biomaterial interaction. Furthermore, diverse methods to achieve continuous monitoring of cell behavior via developments of biosensor integrated high-throughput platforms, and future perspectives on high-throughput screening will be provided.

UR - http://www.scopus.com/inward/record.url?scp=85065072525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065072525&partnerID=8YFLogxK

U2 - 10.2174/1381612825666190207093438

DO - 10.2174/1381612825666190207093438

M3 - Review article

C2 - 30727879

AN - SCOPUS:85065072525

VL - 24

SP - 5458

EP - 5470

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 45

ER -